Some Diabetes Meds Could Lower Odds for Dementia, Parkinson's

THURSDAY, Sept. 19, 2024 -- A specific class of diabetes drug appears to lower people’s risk for dementia and Parkinson’s disease, a new study shows.

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, also known as gliflozins, lower...